Abstract
A defining hallmark of cancer and cancer development is upregulated angiogenesis. The vasculature formed in tumors is structurally abnormal, not organized in the conventional hierarchical arrangement, and more permeable than normal vasculature. These features contribute to leaky, tortuous, and dilated blood vessels, which act to create heterogeneous blood flow, compression of vessels, and elevated interstitial fluid pressure. As such, abnormalities in the tumor vasculature not only affect the delivery of nutrients and oxygen to the tumor, but also contribute to creating an abnormal tumor microenvironment that further promotes tumorigenesis. The role of chemical signaling events in mediating tumor angiogenesis has been well researched; however, the relative contribution of physical cues and mechanical regulation of tumor angiogenesis is less understood. Growing research indicates that the physical microenvironment plays a significant role in tumor progression and promoting abnormal tumor vasculature. Here, we review how mechanical cues found in the tumor microenvironment promote aberrant tumor angiogenesis. Specifically, we discuss the influence of matrix stiffness and mechanical stresses in tumor tissue on tumor vasculature, as well as the mechanosensory pathways utilized by endothelial cells to respond to the physical cues found in the tumor microenvironment. We also discuss the impact of the resulting aberrant tumor vasculature on tumor progression and therapeutic treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The MMTV-PyMT transgenic mouse model is widely used to study mammary tumor progression and metastasis. In the MMTV-PyMT model, mammary gland-specific expression of the polyoma middle T antigen (PyMT) oncogene driven by the upstream mouse mammary tumor virus (MMTV) long terminal repeat promoter results in mammary epithelium transformation and rapid development of multifocal mammary adenocarcinomas and metastatic lesions.
References
Hanahan D, Folkman J (1996) Patterns and emerging mechanisms of the angiogenic switchduring tumorigenesis. Cell 86:353–364
Carmeliet P, Jain RK (2000) Angiogenesis in cancer and other diseases. Nature 407:249–257
Bergers G, Benjamin LE (2003) Tumorigenesis and the angiogenic switch. Nat Rev Cancer 3(6):401–410
Less JR et al (1991) Microvascular architecture in a mammary carcinoma: branching patterns and vessel dimensions. Cancer Res 51(265):265–273
Baluk P, Hashizume H, McDonald DM (2005) Cellular abnormalities of blood vessels as targets in cancer. Curr Opin Genet Dev 15(1):102–111
Dudley AC (2012) Tumor endothelial cells. Cold Spring Harb Perspect Med 2(3):1–18
Aird WC (2012) Endothelial cell heterogeneity. Cold Spring Harb Perspect Med 2(1):a006429–a006429
Aird WC (2009) Molecular heterogeneity of tumor endothelium. Cell Tissue Res 335(1):271–281
Hashizume H et al (2000) Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 156(4):1363–1380
Hobbs SK et al (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci 95(8):4607–4612
Dvorak HF et al (1999) Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis. Curr Top Microbiol Immunol 237:97–132
Bordeleau F et al (2017) Matrix stiffening promotes a tumor vasculature phenotype. Proc Natl Acad Sci 114(3):492–497
Jain RK (2014) Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia. Cancer Cell 26(5):605–622
Lu P, Weaver VM, Werb Z (2012) The extracellular matrix: a dynamic niche in cancer progression. J Cell Biol 196(4):395–406
Daley WP, Peters SB, Larsen M (2008) Extracellular matrix dynamics in development and regenerative medicine. J Cell Sci 121(3):255–264
Kim DH et al (2012) Matrix nanotopography as a regulator of cell function. J Cell Biol 197(3):351–360
Hynes RO (2009) The extracellular matrix: not just pretty fibrils. Science 326(5957):1216–1219
Mongiat, M et al (2016) Extracellular matrix, a hard player in angiogenesis. Int J Mol Sci 17(11):1822
Bonnans C, Chou J, Werb Z (2014) Remodelling the extracellular matrix in development and disease. Nat Rev Mol Cell Biol 15(12):786–801
Mammoto T, Ingber DE (2010) Mechanical control of tissue and organ development. Development 137(9):1407–1420
Provenzano PP et al (2006) Collagen reorganization at the tumor-stromal interface facilitates local invasion. BMC Med 4(1):38–38
Wiseman BS (2002) Stromal effects on mammary gland development and breast cancer. Science 296(5570):1046–1049
Butcher DT, Alliston T, Weaver VM (2009) A tense situation: forcing tumour progression. Nat Rev Cancer 9(2):108–122
Grassian AR, Coloff JL, Brugge JS (2011) Extracellular matrix regulation of metabolism and implications for tumorigenesis. Cold Spring Harb Symp Quant Biol 76:313–324
Morris BA et al (2016) Collagen matrix density drives the metabolic shift in breast cancer cells. EBioMedicine 13:146–156
Paszek MJ et al (2005) Tensional homeostasis and the malignant phenotype. Cancer Cell 8(3):241–254
Wozniak MA et al (2003) ROCK-generated contractility regulates breast epithelial cell differentiation in response to the physical properties of a three-dimensional collagen matrix. J Cell Biol 163(3):583–595
Provenzano PP et al (2009) Matrix density-induced mechanoregulation of breast cell phenotype, signaling and gene expression through a FAK-ERK linkage. Oncogene 28(49):4326–4343
Samani A et al (2003) Measuring the elastic modulus of ex vivo small tissue samples. Phys Med Biol 48(14):2183–2198
Gefen A, Dilmoney B (2007) Mechanics of the normal woman’s breast. Technol Health Care 15(4):259–271
Jain RK (1994) Barriers to drug delivery in solid tumors. Sci Am 271(1):58–65
Less JR et al (1992) Interstitial hypertension in human breast and colorectal tumors. Cancer Res 52(22):6371–6374
Nathanson SD, Nelson L (1994) Interstitial fluid pressure in breast cancer, benign breast conditions, and breast parenchyma. Ann Surg Oncol 1(4):333–338
Stylianopoulos T et al (2012) Causes, consequences, and remedies for growth-induced solid stress in murine and human tumors. Proc Natl Acad Sci 109(38):15101–15108
Jain RK, Tong RT, Munn LL (2007) Effect of vascular normalization by antiangiogenic therapy on interstitial hypertension, peritumor edema, and lymphatic metastasis: insights from a mathematical model. Cancer Res 67(6):2729–2735
Ebihara T et al (2000) Changes in extracellular matrix and tissue viscoelasticity in bleomycin-induced lung fibrosis. Temporal aspects. Am J Respir Crit Care Med 162(4):1569–1576
Aukland K, Reed RK (1993) Interstitial-lymphatic mechanisms in the control of extracellular fluid volume. Physiol Rev 73(1):1–78
Mori T et al (2015) Interstitial fluid pressure correlates clinicopathological factors of lung cancer. Ann Thorac Cardiovasc Surg 21(3):201–208
Kumar S, Weaver VM (2009) Mechanics, malignancy, and metastasis: the force journey of a tumor cell. Cancer Metastasis Rev 28(1–2):113–127
Boucher Y et al (1997) Interstitial fluid pressure in intracranial tumours in patients and in rodents. Br J Cancer 75(6):829–836
Arbit E, Lee J, Diresta G (1994) Interstitial hypertension in human brain tumors: possible role in peritumoral edema formation. In: Nagai H, Kamlya K (eds) Intracranial pressure, 9th edn. Springer, Tokyo
Goel S et al (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91(3):1071–1121
Navalitloha Y et al (2006) Therapeutic implications of tumor interstitial fluid pressure in subcutaneous RG-2 tumors. Neuro-Oncology 8(3):227–233
Nia HT et al (2016) Solid stress and elastic energy as measures of tumour mechanopathology. Nat Biomed Eng 1. https://doi.org/10.1038/s41551-016-0004
Guyton AC, Hall JE (2006) Textbook of medical physiology, Guyton physiology series. Elsevier Saunders, Amsterdam
Wells RG (2008) The role of matrix stiffness in regulating cell behavior. Hepatology 47(4):1394–1400
Yeh WC et al (2002) Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 28(4):467–474
Hori K et al (1986) Increased tumor tissue pressure in association with the growth of rat tumors. Jpn J Cancer Res 77(1):65–73
Kawano S et al (2015) Assessment of elasticity of colorectal cancer tissue, clinical utility, pathological and phenotypical relevance. Cancer Sci 106(9):1232–1239
Johnson LA et al (2013) Matrix stiffness corresponding to strictured bowel induces a fibrogenic response in human colonic fibroblasts. Inflamm Bowel Dis 19(5):891–903
Nebuloni M et al (2016) Insight on colorectal carcinoma infiltration by studying perilesional extracellular matrix. Sci Rep 6:22522
Netti PA et al (2000) Role of extracellular matrix assembly in interstitial transport in solid tumors role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60:2497–2503
Stanczyk M et al (2010) Lack of functioning lymphatics and accumulation of tissue fluid/lymph in interstitial “lakes” in colon cancer tissue. Lymphology 43(4):158–167
Levental I, Georges PC, Janmey PA (2007) Soft biological materials and their impact on cell function. Soft Matter 3:2990306
Lee JW et al (2011) Palpation device for the identification of kidney and bladder cancer: a pilot study. Yonsei Med J 52(5):768–772
Wortman T, Hsu F, Slocum A (2016) A novel phantom tissue model for skin elasticity quantification. ASME J Med Devices 10(2):020961
Boucher Y et al (1991) Interstitial hypertension in superficial metastatic melanomas in humans. Cancer Res 51(24):6691–6694
Rice AJ et al (2017) Matrix stiffness induces epithelial-mesenchymal transition and promotes chemoresistance in pancreatic cancer cells. Oncogene 6(7):e352
Provenzano PP et al (2012) Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. Cancer Cell 21(3):418–429
Zysset PK et al (1999) Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur. J Biomech 32(10):1005–1012
Odgaard A, Linde F (1991) The underestimation of Young’s modulus in compressive testing of cancellous bone specimens. J Biomech 24(8):691–698
Nathan SS et al (2008) Tumor interstitial fluid pressure may regulate angiogenic factors in osteosarcoma. J Orthop Res 26(11):1520–1525
Davis GE, Senger DR (2005) Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization. Circ Res 97(11):1093–1107
Ingber DE, Folkman J (1989) Mechanochemical switching between growth and differentiation during fibroblast growth factor-stimulated angiogenesis in vitro: role of extracellular matrix. J Cell Biol 109(1):317–330
Vailhé B et al (1997) In vitro angiogenesis is modulated by the mechanical properties of fibrin gels and is related to alpha(v)beta3 integrin localization. In Vitro Cell Dev Biol Anim 33(10):763–773
Ghajar CM et al (2008) The effect of matrix density on the regulation of 3-D capillary morphogenesis. Biophys J 94(5):1930–1941
Rao RR et al (2012) Matrix composition regulates three-dimensional network formation by endothelial cells and mesenchymal stem cells in collagen fibrin materials. Angiogenesis 15(2):253–264
Kniazeva E, Putnam AJ (2009) Endothelial cell traction and ECM density influence both capillary morphogenesis and maintenance in 3-D. Am J Physiol Cell Physiol 297(1):C179–C187
Mason BN et al (2013) Tuning three-dimensional collagen matrix stiffness independently of collagen concentration modulates endothelial cell behavior. Acta Biomater 9(1):4635–4644
Sieminski AL, Hebbel RP, Gooch KJ (2004) The relative magnitudes of endothelial force generation and matrix stiffness modulate capillary morphogenesis in vitro. Exp Cell Res 297(2):574–584
LaValley DJ, Reinhart-King CA (2014) Matrix stiffening in the formation of blood vessel. Adv Regen Biol 1:1–18
Wu Y, Al-Ameen MA, Ghosh G (2014) Integrated effects of matrix mechanics and vascular endothelial growth factor (VEGF) on capillary sprouting. Ann Biomed Eng 42(5):1024–1036
Cox TR, Erler JT (2011) Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis Model Mech 4(2):165–178
Bershadsky AD, Balaban NQ, Geiger B (2003) Adhesion-dependent cell mechanosensitivity. Annu Rev Cell Dev Biol 19(1):677–695
Ingber DE (1991) Integrins as mechanochemical transducers. Curr Opin Cell Biol 3(5):841–848
Polet F, Feron O (2013) Endothelial cell metabolism and tumour angiogenesis: glucose and glutamine as essential fuels and lactate as the driving force. J Intern Med 273(2):156–165
Liu Z et al (2010) Mechanical tugging force regulates the size of cell-cell junctions. Proc Natl Acad Sci 107(22):9944–9949
Croix BS et al (2000) Genes expressed in human tumor endothelium. Science 289(5482):1197–1202
Bussolati B et al (2003) Altered angiogenesis and survival in human tumor-derived endothelial cells. FASEB J 17(9):1159–1161
Ghosh K et al (2008) Tumor-derived endothelial cells exhibit aberrant Rho-mediated mechanosensing and abnormal angiogenesis in vitro. Proc Natl Acad Sci 105(32):11305–11310
Francis-Sedlak ME et al (2010) Collagen glycation alters neovascularization in vitro and in vivo. Microvasc Res 80(1):3–9
Lee PF et al (2013) Angiogenic responses are enhanced in mechanically and microscopically characterized, microbial transglutaminase crosslinked collagen matrices with increased stiffness. Acta Biomater 9(7):7178–7190
Whittington CF, Yoder MC, Voytik-Harbin SL (2013) Collagen-polymer guidance of vessel network formation and stabilization by endothelial colony forming cells in vitro. Macromol Biosci 13(9):1135–1149
Yao C et al (2008) The effect of cross-linking of collagen matrices on their angiogenic capability. Biomaterials 29(1):66–74
Yamamura N et al (2007) Effects of the mechanical properties of collagen gel on the in vitro formation of microvessel networks by endothelial cells. Tissue Eng 13(7):1443–1453
Fantozzi A, Christofori G (2006) Mouse models of breast cancer metastasis. Breast Cancer Res 8(4):212
Sternlicht MD, Werb Z (2001) How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 17(1):463–516
Haage A, Schneider IC (2014) Cellular contractility and extracellular matrix stiffness regulate matrix metalloproteinase activity in pancreatic cancer cells. FASEB J 28(8):3589–3599
Jain RK, Martin JD, Stylianopoulos T (2014) The role of mechanical forces in tumor growth and therapy. Annu Rev Biomed Eng 16(1):321–346
Stylianopoulos T et al (2013) Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res 73(13):3833–3841
Harris AK, Stopak D, Wild P (1981) Fibroblast traction as a mechanism for collagen morphogenesis. Nature 290(5803):249–251
Miron-Mendoza M, Seemann J, Grinnell F (2008) Collagen fibril flow and tissue translocation coupled to fibroblast migration in 3D collagen matrices. Mol Biol Cell 19(5):2051–2058
Shi Q et al (2014) Rapid disorganization of mechanically interacting systems of mammary acini. Proc Natl Acad Sci 111(2):658–663
Wang H et al (2014) Long-range force transmission in fibrous matrices enabled by tension-driven alignment of fibers. Biophys J 107(11):2592–2603
Kilarski WW et al (2009) Biomechanical regulation of blood vessel growth during tissue vascularization. Nat Med 15(6):657–664
Korff T, Augustin HG (1999) Tensional forces in fibrillar extracellular matrices control directional capillary sprouting. J Cell Sci 112(19):3249–3258
Kenyon BM et al (1996) A model of angiogenesis in the mouse cornea. Invest Ophthalmol Vis Sci 37(8):1625–1632
Lockhart AC et al (2003) A clinical model of dermal wound angiogenesis. Wound Repair Regen 11(4):306–313
Padera TP et al (2004) Pathology: cancer cells compress intratumour vessels. Nature 427(6976):695
Boucher Y, Jain RK (1992) Microvascular pressure is the principal driving force for interstitial hypertension in solid tumors: implications for vascular collapse. Cancer Res 52(18):5110–5114
Potente M, Mäkinen T (2017) Vascular heterogeneity and specialization in development and disease. Nat Rev Mol Cell Biol 18(8):477
Helmlinger G et al (1991) Effects of pulsatile flow on cultured vascular endothelial cell morphology. J Biomech Eng 113(2):123–131
Wang Y et al (2007) Selective adapter recruitment and differential signaling networks by VEGF vs. shear stress. Proc Natl Acad Sci 104(21):8875–8879
Kappas NC et al (2008) The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching. J Cell Biol 181(5):847–858
Price GM et al (2010) Effect of mechanical factors on the function of engineered human blood microvessels in microfluidic collagen gels. Biomaterials 31(24):6182–6189
Song JW, Munn LL (2011) Fluid forces control endothelial sprouting. Proc Natl Acad Sci 108(37):15342–15347
Galie Pa et al (2014) Fluid shear stress threshold regulates angiogenic sprouting. Proc Natl Acad Sci 111(22):7968–7973
Vickerman V, Kamm RD (2012) Mechanism of a flow-gated angiogenesis switch: early signaling events at cell–matrix and cell–cell junctions. Integr Biol 4(8):863–874
Ausprunk DH, Folkman J (1977) Migration and proliferation of endothelial cells in preformed and newly formed blood vessels during tumor angiogenesis. Microvasc Res 14(1):53–65
Chauhan VP et al (2014) Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. Cancer Cell 26(1):14–15
Li S, Huang NF, Hsu S (2005) Mechanotransduction in endothelial cell migration. J Cell Biochem 96(6):1110–1126
Li YSJ, Haga JH, Chien S (2005) Molecular basis of the effects of shear stress on vascular endothelial cells. J Biomech 38(10):1949–1971
Kutys ML, Chen CS (2016) Forces and mechanotransduction in 3D vascular biology. Curr Opin Cell Biol 42:73–79
Conway DE et al (2013) Fluid shear stress on endothelial cells modulates mechanical tension across VE-cadherin and PECAM-1. Curr Biol 23(11):1024–1030
Maniotis AJ, Chen CS, Ingber DE (1997) Demonstration of mechanical connections between integrins, cytoskeletal filaments, and nucleoplasm that stabilize nuclear structure. Proc Natl Acad Sci 94(3):849–854
Stevenson RP, Veltman D, Machesky LM (2012) Actin-bundling proteins in cancer progression at a glance. J Cell Sci 125:1073–1079
Alenghat FJ, Ingber DE (2002) Mechanotransduction: all signals point to cytoskeleton, matrix, and integrins. Sci Signal 2002(119):pe6
Schwarz US, Gardel ML (2012) United we stand – integrating the actin cytoskeleton and cell–matrix adhesions in cellular mechanotransduction. J Cell Sci 125(13):3051–3060
Katsumi A et al (2004) Integrins in mechanotransduction. J Biol Chem 279(13):12001–12004
Giancotti FG, Ruoslahti E (1999) Integrin signaling. Science 285(5430):1028–1033
Miranti CK, Brugge JS (2002) Sensing the environment: a historical perspective on integrin signal transduction. Nat Cell Biol 4(4):E83–E90
Matthews BD et al (2006) Cellular adaptation to mechanical stress: role of integrins, Rho, cytoskeletal tension and mechanosensitive ion channels. J Cell Sci 119(3):508–518
Reinhart-King CA, Dembo M, Hammer DA (2005) The dynamics and mechanics of endothelial cell spreading. Biophys J 89(1):676–689
Zanotelli MR, Bordeleau F, Reinhart-King CA (2017) Subcellular regulation of cancer cell mechanics. Curr Opin Biomed Eng 1:8–14
Kraning-Rush CM, Califano JP, Reinhart-King CA (2012) Cellular traction stresses increase with increasing metastatic potential. PLoS One 7(2):e32572–e32572
Weis SM, Cheresh DA (2011) αV integrins in angiogenesis and cancer. Cold Spring Harb Perspect Med 1(1):1–14
Paszek MJ, Weaver VM (2004) The tension mounts: mechanics meets morphogenesis and malignancy. J Mammary Gland Biol Neoplasia 9(4):325–342
Tzima E et al (2001) Activation of integrins in endothelial cells by fluid shear stress mediates Rho-dependent cytoskeletal alignment. EMBO J 20(17):4639–4647
Nikolopoulos SN et al (2004) Integrin β4 signaling promotes tumor angiogenesis. Cancer Cell 6(5):471–483
Ruoslahti E (2000) Targeting tumor vasculature with homing peptides from phage display. Semin Cancer Biol 10(6):435–442
Ruoslahti E (2002) Specialization of tumour vasculature. Nat Rev Cancer 2(2):83–90
Senger DR et al (1997) Angiogenesis promoted by vascular endothelial growth factor: regulation through α1β1 and α2β1 integrins. Proc Natl Acad Sci 94(25):13612–13617
Senger D et al (2002) The α1β1 and α2β1 integrins provide critical support for vascular endothelial growth factor signaling, endothelial cell migration, and tumor angiogenesis. Am J Pathol 160(1):195–204
Kim S et al (2000) Regulation of angiogenesis in vivo by ligation of integrin α5β1 with the central cell-binding domain of fibronectin. Am J Pathol 156(4):1345–1362
Brooks PC et al (1994) Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79(7):1157–1164
Friedlander M et al (1995) Definition of two angiogenic pathways by distinct αv integrins. Science 270(5241):1500–1502
Hood JD et al (2003) Differential alphav integrin-mediated Ras-ERK signaling during two pathways of angiogenesis. J Cell Biol 162(5):933–943
Brooks PC, Clark RAF, Cheresh DA (1994) Requirement of vascular integrin αvβ3 for angiogenesis. Science 264(5158):569–571
Soldi R et al (1999) Role of αvβ3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18(4):882–892
Borges E, Jan Y, Ruoslahti E (2000) Platelet-derived growth factor receptor beta and vascular endothelial growth factor receptor 2 bind to the beta 3 integrin through its extracellular domain. J Biol Chem 275(51):39867–39873
Brooks PC et al (1995) Antiintegrin αvβ3 blocks human breast cancer growth and angiogenesis in human skin. J Clin Investig 96(4):1815–1822
Erdreich-Epstein A et al (2000) Integrins alpha(v)beta3 and alpha(v)beta5 are expressed by endothelium of high-risk neuroblastoma and their inhibition is associated with increased endogenous ceramide. Cancer Res 60(3):712–721
Eliceiri BP, Cheresh Da (1999) The role of αv integrins during angiogenesis: insights into potential mechanisms of action and clinical development. J Clin Dev 103(9):1227–12330
Kumar CC et al (2001) Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist. Cancer Res 61(5):2232–2238
Bazzoni G, Dejana E (2004) Endothelial cell-to-cell junctions: molecular organization and role in vascular homeostasis. Physiol Rev 84(3):869–901
Dorland YL, Huveneers S (2017) Cell–cell junctional mechanotransduction in endothelial remodeling. Cell Mol Life Sci 74(2):279–292
Hahn C, Schwartz MA (2009) Mechanotransduction in vascular physiology and atherogenesis. Nat Rev Mol Cell Biol 10(1):53–62
Lakshmikanthan S et al (2015) Rap1 promotes endothelial mechanosensing complex formation, NO release and normal endothelial function. EMBO Rep 16(5):628–637
Coon BG et al (2015) Intramembrane binding of VE-cadherin to VEGFR2 and VEGFR3 assembles the endothelial mechanosensory complex. J Cell Biol 208(7):975–986
Conway D, Schwartz MA (2012) Lessons from the endothelial junctional mechanosensory complex. F1000 Biol Rep 4(1):2–7
Collins C et al (2012) Localized tensional forces on PECAM-1 elicit a global mechanotransduction response via the integrin-RhoA pathway. Curr Biol 22(22):2087–2094
Murakami M, Simons M (2009) Regulation of vascular integrity. J Mol Med 87(6):571–582
Fraccaroli A et al (2015) Endothelial alpha-parvin controls integrity of developing vasculature and is required for maintenance of cell–cell junctions. Circ Res 117(1):19–40
Huynh J et al (2011) Age-related intimal stiffening enhances endothelial permeability and leukocyte transmigration. Sci Transl Med 3(112):112ra122
Mazzone M et al (2009) Heterozygous deficiency of PHD2 restores tumor oxygenation and inhibits metastasis via endothelial normalization. Cell 136(5):839–851
Giannotta M, Trani M, Dejana E (2013) VE-cadherin and endothelial adherens junctions: active guardians of vascular integrity. Dev Cell 26(5):441–454
van Nieuw Amerongen GP et al (2003) Involvement of RhoA/Rho kinase signaling in VEGF-induced endothelial cell migration and angiogenesis in vitro. Arterioscler Thromb Vasc Biol 23(2):211–217
Shay-salit A et al (2002) VEGF receptor 2 and the adherens junction as a mechanical transducer in vascular endothelial cells. Proc Natl Acad Sci 99(14):9462–9467
Koch S, Claesson-Welsh L (2012) Signal transduction by vascular endothelial growth factor receptors. Cold Spring Harb Perspect Med 2(7):a006502
Kubo H et al (2000) Involvement of vascular endothelial growth factor receptor-3 in maintenance of integrity of endothelial cell lining during tumor angiogenesis. Blood 96(2):546–553
Laakkonen P et al (2007) Vascular endothelial growth factor receptor 3 is involved in tumor angiogenesis and growth. Cancer Res 67(2):593–599
Mammoto A et al (2009) A mechanosensitive transcriptional mechanism that controls angiogenesis. Nature 457(7233):1103–1108
Sack KD, Teran M, Nugent MA (2016) Extracellular matrix stiffness controls vegf signaling and processing in endothelial cells. J Cell Physiol 231(9):2026–2039
Yang MT, Reich DH, Chen CS (2011) Measurement and analysis of traction force dynamics in response to vasoactive agonists. Integr Biol 3(6):663–674
Goel HL, Mercurio AM (2013) VEGF targets the tumour cell. Nat Rev Cancer 13(12):871–882
Ogawa K et al (2000) The ephrin-A1 ligand and its receptor, EphA2, are expressed during tumor neovascularization. Oncogene 19(52):6043–6052
Shin D et al (2001) Expression of EphrinB2 identifies a stable genetic difference between arterial and venous vascular smooth muscle as well as endothelial cells, and marks subsets of microvessels at sites of adult neovascularization. Dev Biol 230(2):139–150
Gale NW et al (2001) Ephrin-B2 selectively marks arterial vessels and neovascularization sites in the adult, with expression in both endothelial and smooth-muscle cells. Dev Biol 230(2):151–160
Martial S (2016) Involvement of ion channels and transporters in carcinoma angiogenesis and metastasis. Am J Physiol Cell Physiol 310(9):C710–C727
Liberati S et al (2013) Oncogenic and anti-oncogenic effects of transient receptor potential channels. Curr Top Med Chem 13(3):344–366
Lehen'kyi V, Prevarskaya N (2011) Oncogenic TRP channels. Adv Exp Med Biol 704:929–945
Lehen’kyi V, Prevarskaya N (2011) Study of TRP channels in cancer cells. In: Zhu MX (ed) TRP channels. CRC Press/Taylor & Francis. Llc., Boca Raton (FL)
Kwan H-Y, Huang Y, Yao X (2007) TRP channels in endothelial function and dysfunction. Biochim Biophys Acta 1772(8):907–914
Adapala RK et al (2016) Activation of mechanosensitive ion channel TRPV4 normalizes tumor vasculature and improves cancer therapy. Oncogene 35(3):314–322
Thoppil RJ et al (2016) TRPV4 channels regulate tumor angiogenesis via modulation of Rho/Rho kinase pathway. Oncotarget 7(18): 25849–25861
Thodeti CK et al (2009) TRPV4 channels mediate cyclic strain-induced endothelial cell reorientation through integrin-to-integrin signaling. Circ Res 104(9):1123–1130
Chachisvilis M, Zhang YL, Frangos JA (2006) G protein-coupled receptors sense fluid shear stress in endothelial cells. Proc Natl Acad Sci 103(42):15463–15468
Dorsam RT, Gutkind JS (2007) G-protein-coupled receptors and cancer. Nat Rev Cancer 7(2):79–94
Richard DE, Vouret-Craviari V, Pouysségur J (2001) Angiogenesis and G-protein-coupled receptors: signals that bridge the gap. Oncogene 20(1):1556–1562
O'Hayre M, Degese MS, Gutkind JS (2014) Novel insights into G protein and G protein-coupled receptor signaling in cancer. Curr Opin Cell Biol 27:126–135
Pai R et al (2001) PGE2 stimulates VEGF expression in endothelial cells via ERK2/JNK1 signaling pathways. Biochem Biophys Res Commun 286(5):923–928
Visentin B et al (2006) Validation of an anti-sphingosine-1-phosphate antibody as a potential therapeutic in reducing growth, invasion, and angiogenesis in multiple tumor lineages. Cancer Cell 9(3):225–238
Vouret-Craviari V, Grall D, Van Obberghen-Schilling E (2003) Modulation of Rho GTPase activity in endothelial cells by selective proteinase-activated receptor (PAR) agonists. J Thromb Haemost 1(5):1103–1111
Evan-Ram S et al (1998) Thrombin receptor overexpression in malignant and physiological invasion processes. Nature 4(8):909–914
McDonald DM, Baluk P (2002) Significance of blood vessel leakiness in cancer. Cancer Res 62(18):5381–5385
Pries AR et al (2010) The shunt problem: control of functional shunting in normal and tumour vasculature. Nat Rev Cancer 10(8):587–593
Kamoun WS et al (2010) Simultaneous measurement of RBC velocity, flux, hematocrit and shear rate in vascular networks. Nat Methods 7(8):655–660
Baish JW et al (2011) Scaling rules for diffusive drug delivery in tumor and normal tissues. Proc Natl Acad Sci 108(5):1799–1803
Chauhan VP et al (2011) Delivery of molecular and nanoscale medicine to tumors: transport barriers and strategies. Annu Rev Chem Biomol Eng 2(1):281–298
Heldin C-H et al (2004) High interstitial fluid pressure — an obstacle in cancer therapy. Nat Rev Cancer 4(10):806–813
Jain RK (2013) Normalizing tumor microenvironment to treat cancer: bench to bedside to biomarkers. J Clin Oncol 31(17):2205–2218
Hurwitz H (2004) Integrating the anti-VEGF-A humanized monoclonal antibody bevacizumab with chemotherapy in advanced colorectal cancer. Clin Colorectal Cancer 4(Suppl 2):S62–S68
Maes H et al (2014) Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell 26(2):190–206
Potente M, Gerhardt H, Carmeliet P (2011) Basic and therapeutic aspects of angiogenesis. Cell 146(6):873–887
Welti J et al (2013) Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer. J Clin Investig 123(8):3190–3200
Bergers G, Hanahan D (2008) Modes of resistance to anti-angiogenic therapy. Nat Rev Cancer 8(8):592–603
Jain RK (2005) Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307(5706):58–62
Nagy JA et al (2009) Why are tumour blood vessels abnormal and why is it important to know? Br J Cancer 100(6):865–869
Wilson WR, Hay MP (2011) Targeting hypoxia in cancer therapy. Nat Rev Cancer 11(6):393–410
Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93(4):266–276
Minchinton AI, Tannock IF (2006) Drug penetration in solid tumours. Nat Rev Cancer 6(8):583–592
Acknowledgments
The authors gratefully acknowledge support from the National Heart, Lung, and Blood Institute (HL127499) to CAR-K and a National Science Foundation Graduate Research Fellowship under Grant No. DGE-1650441 to MRZ.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Zanotelli, M.R., Reinhart-King, C.A. (2018). Mechanical Forces in Tumor Angiogenesis. In: Dong, C., Zahir, N., Konstantopoulos, K. (eds) Biomechanics in Oncology. Advances in Experimental Medicine and Biology, vol 1092. Springer, Cham. https://doi.org/10.1007/978-3-319-95294-9_6
Download citation
DOI: https://doi.org/10.1007/978-3-319-95294-9_6
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-95293-2
Online ISBN: 978-3-319-95294-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)